Deciphera Pharmaceuticals Inc (DCPH)
25.46
+0.02
(+0.06%)
USD |
NASDAQ |
May 17, 16:00
25.46
0.00 (0.00%)
After-Hours: 20:00
Deciphera Pharmaceuticals Cash from Investing (TTM): 110.59M for March 31, 2024
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
| Date | Value |
|---|---|
| March 31, 2024 | 110.59M |
| December 31, 2023 | 12.55M |
| September 30, 2023 | 26.65M |
| June 30, 2023 | -20.82M |
| March 31, 2023 | -129.38M |
| December 31, 2022 | -34.31M |
| September 30, 2022 | 48.34M |
| June 30, 2022 | 68.85M |
| March 31, 2022 | 112.59M |
| December 31, 2021 | 176.85M |
| September 30, 2021 | 123.98M |
| June 30, 2021 | 111.36M |
| March 31, 2021 | 154.06M |
| Date | Value |
|---|---|
| December 31, 2020 | 28.46M |
| September 30, 2020 | -15.94M |
| June 30, 2020 | -312.57M |
| March 31, 2020 | -282.56M |
| December 31, 2019 | -460.52M |
| September 30, 2019 | -462.50M |
| June 30, 2019 | -167.91M |
| March 31, 2019 | -181.69M |
| December 31, 2018 | -2.194M |
| September 30, 2018 | -2.021M |
| June 30, 2018 | -2.007M |
| March 31, 2018 | -0.523M |
| December 31, 2017 | -0.406M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-462.50M
Minimum
Sep 2019
176.85M
Maximum
Dec 2021
-45.61M
Average
19.60M
Median
Cash from Investing (TTM) Benchmarks
| Bristol-Myers Squibb Co | -21.70B |
| Dynavax Technologies Corp | -98.76M |
| Gilead Sciences Inc | -3.646B |
| Esperion Therapeutics Inc | 17.43M |
| SINTX Technologies Inc | -0.438M |